5^th International Summit on GMP, GCP & Quality Control August 12-13, 2016 Toronto, Ontario, Canada

ConferenceSeries Ltd Conferences invites all the participants from all over the world to attend ‘5^th International Summit on GMP, GCP & Quality Control (GMP Summit 2016)' during August 12-13, 2016 at Toronto, Canada which covers on all aspects of the pharmaceutical sciences, manufacturing, quality with strong emphasis on originality and scientific quality.

The main theme of the conference is “Taking on challenges and exploring opportunities to achieve Compliance and ensuring great Quality Products”.

GMP Summit 2016 is the learning of ensuring that products are consistently produced and controlled according to quality standards. It is designed to minimize the risks involved in any pharmaceutical production that cannot be eliminated through testing the final product. GMP covers all aspects of production; from the starting materials, premises and equipment to the training and personal hygiene of staff. Advanced studies are being made to improvise quality of products, reduce safety risk and cost, and enhance international credibility and public image and many more.

ConferenceSeries Ltd organizes a conference series of 3000+ Global Events inclusive of 600+ Conferences, 1200+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access Journals which contains over 70000 eminent personalities, reputed scientists as editorial board members.

Track-1: Good Manufacturing Practices: The Gap Within

Good Manufacturing Practice is the part of quality management which ensures that products are consistently produced and controlled according to the quality standards appropriate to their intended use and as required by the marketing authorization, clinical trial authorization or product specification. Good Manufacturing practices conference aims at both production and Quality Control. Current Good Manufacturing Practices (cGMP) is aimed primarily at managing and minimizing the risks inherent in pharmaceutical manufacture to ensure the quality, safety and efficacy of products. FDA regulates the quality of pharmaceuticals very carefully. Current Trends in the FDA is the main regulatory standard for ensuring pharmaceutical quality.

Related Conferences:

Global Pharmaceutical Industry Summit, August 22-24, 2016, Vienna, Austria; Pharma Marketing Conference, November 17-19, 2016, Alicante, Spain; 6^th Pharmaceutical Conference on Regulatory Affairs and IPR, Sept 29- Oct 01, 2016 Orlando, USA; Conference on Generic Drug Market and Contract Manufacturing, Oct 31- Nov 02, 2016, Valencia, Spain; 6^th Biologics and Biosimilars Conference, October 19-21, 2016, Houston, USA; 2016; ICPM 2016 : 18th Conference on Pharmaceutical Manufacturing, July 25-26, 2016, Paris, France; The Premier Industry Conference for Organizations using SAP, October 16-18, 2016, Detroit, USA; NZIFST Conference 2016, July 4-7, 2016, Rotorua, New Zealand; eLearning Good Manufacturing Practice (GMP), September 26-27, 2016   London, UK; 21st Annual GMP Conference By The Sea, August 29-31, 2016, Maryland, USA. International Pharmaceutical Federation (FIP), Pharmaceutical Society of Australia, Chinese Pharmaceutical Association, American Association of Pharmaceutical Scientists (AAPS), Austrian Pharmaceutical Society (APS).

Track-2: Current Regulations and Quality Standards

Roles of pharmaceutical inspection convention and co-operation scheme (PIC/S) are to improve co-operation in the field of Good Manufacturing Practices between regulatory authorities and the pharmaceutical industry. The FDA regulations and CFR are responsible for protecting and promoting public health through the regulation and supervision of all the products available in the market to ensure patient compliance. EU-GMP guidelines are needed to maintain the products quality which is stricter when compared to WHO-GMP guidelines.

Related Conferences:

Global Pharmaceutical Industry Summit, August 22-24, 2016, Vienna, Austria; Pharma Marketing Conference, November 17-19, 2016, Alicante, Spain; 6^th Pharmaceutical Conference on Regulatory Affairs and IPR, Sept 29- Oct 01, 2016 Orlando, USA; Conference on Generic Drug Market and Contract Manufacturing, Oct 31- Nov 02, 2016, Valencia, Spain; 6^th  Biologics and Biosimilars Conference, October 19-21, 2016, Houston,  USA; ICPRA 2016 : 18th Conference on Pharmaceutical Regulatory Affairs, August 8 - 9, 2016,Venice, Italy; Global Pharmaceutical Regulatory Affairs Summit, October 18 – 20, 2016, Berlin, Germany; 22nd Asia Pacific Quality Conference, November 20-23, 2016, Rotorua, New Zealand; eLearning Good Manufacturing Practice (GMP), September 26-27, 2016   London, UK; 21st Annual GMP Conference By The Sea, August 29-31, 2016, Maryland, USA; Canadian Society for Pharmaceutical Sciences (CSPS), Drug Information Association (DIA), International Society for Pharmaceutical Engineering (ISPE), National Association of Pharmacy Regulatory Authorities (NAPRA), Pharmaceutical Research and Manufacturers of America (PhRMA).

Track-3: Current GMP Guidelines (cGMP)

CGMP refers to the Current Good Manufacturing Practice regulations enforced by the US FDA. CGMPs provide for systems that assure proper design, monitoring, and control of manufacturing processes and facilities. Adherence to the cGMP regulations assures the identity, strength, quality, and purity of drug products by requiring that manufacturers of medications adequately control manufacturing operations. This includes establishing strong quality management systems, obtaining appropriate quality raw materials, establishing robust operating procedures, detecting and investigating product quality deviations, and maintaining reliable testing laboratories.

Related Conferences:

Global Pharmaceutical Industry Summit, August 22-24, 2016, Vienna, Austria; Pharma Marketing Conference, November 17-19, 2016, Alicante, Spain; 6^th Pharmaceutical Conference on Regulatory Affairs and IPR, Sept 29- Oct 01, 2016, Orlando, USA; Conference on Generic Drug Market and Contract Manufacturing, Oct 31- Nov 02, 2016, Valencia, Spain; 6^th Biologics and Biosimilars Conference, October 19-21, 2016, Houston,Texas, USA; 18th Conference on Pharmaceutical Regulatory Affairs, August 8 - 9, 2016,Venice, Italy; Global Pharmaceutical Regulatory Affairs Summit, October 18 – 20, 2016, Berlin, Germany; The Premier Industry Conference for Organizations using SAP, October 16-18, 2016, Detroit, USA; NZIFST Conference 2016, July 4-7, 2016, Rotorua, New Zealand; 21st Annual GMP Conference By The Sea, August 29-31, 2016, Maryland, USA; Regulatory Affairs Professionals Society (RAPS), Food & Drug Administration (FDA) ,The European Federation of Pharmaceutical Industries and Associations (EFPIA), The European Generic Medicines Association (EGA), The Controlled Release Society (CRS).

Track-4: The Role of 'c' in cGMP

The CGMP requirements were established to be flexible in order to allow each manufacturer to decide individually how to best implement the necessary controls by using scientifically design, processing methods, and testing procedures. The flexibility in these regulations allows companies to use modern technologies and innovative approaches to achieve higher quality through continual improvement. Accordingly, the "C" in CGMP stands for "current," requiring companies to use technologies and systems that are up-to-date in order to comply with the regulations. Systems and equipment that may have been "top-of-the-line" to prevent contamination, mix-ups, and errors 10 or 20 years ago may be less than adequate by today's quality standards.

Related Conferences:

Global Pharmaceutical Industry Summit, August 22-24, 2016, Vienna, Austria; Pharma Marketing Conference, November 17-19, 2016, Alicante, Spain; 6^th Pharmaceutical Conference on Regulatory Affairs and IPR, Sept 29- Oct 01, 2016, Orlando, USA; Conference on Generic Drug Market and Contract Manufacturing, Oct 31- Nov 02, 2016, Valencia, Spain; 6^th  Biologics and Biosimilars Conference, October 19-21, 2016, Houston,  USA; 18th Conference on Pharmaceutical Manufacturing, July 25-26, 2016, Paris, France; The Premier Industry Conference for Organizations using SAP, October 16-18, 2016, Detroit, USA; NZIFST Conference 2016, July 4-7, 2016, Rotorua, New Zealand; Compliance Online Pharma Summit 2016 – Risk Control and Compliance, October 6-7, 2016, Philadelphia, USA; 21st Annual GMP Conference By The Sea, August 29-31, 2016, Maryland, USA; Regulatory Affairs Professionals Society (RAPS), Food & Drug Administration (FDA) ,The European Federation of Pharmaceutical Industries and Associations (EFPIA), National Association of Pharmacy Regulatory Authorities (NAPRA), Pharmaceutical Research and Manufacturers of America (PhRMA).

Track-5: Good Clinical Practices and Good Laboratory Practices

The role of ICH in designing GCP principles is to provide an ethical treatment to the subjects who are involved in the clinical trials. Conference on Good Clinical Practices is important because it is an international ethical and scientific quality standard for designing, conducting, recording and reporting trials that involve the participation of human subjects. The GLP Principles describe requirements for and provide general guidance on the conduct of all nonclinical health and environmental safety studies, including invitro studies. Pre-clinical trials assess the toxicity of a drug and examine its potential effects on the human body. These trials are conducted in-vitro which is required to proceed with clinical trials. Good laboratory practices should be followed for these pre-clinical trials.

Related Conferences:

7^th Conference on Pharmacovigilance, August 22-24, 2016, Vienna, Austria; 3^rd  World Congress on Pharmacology, August 08-10, 2016, Birmingham, UK; 2^nd Clinical Trials Conference, August 22-24, 2016, Philadelphia, USA; 6^th Pharmacovigilance Congress, September 28-30, 2016, Toronto, Canada; Global Pharmaceutical Industry Summit, August 22-24, 2016, Vienna, Austria; 2^nd Pharmacovigilance Conference 2016, June 14-15, 2016, London UK; Canada Talks Pharma 2016: A New Way Forward in Clinical Trials, May 25-26, 2016, Montreal, Canada; CTMD 2016 — The 2nd Congress on Clinical Trials for Medical Devices, September 21-22, 2016, Berlin, Germany; WCTD2016 — The World Congress on Clinical Trials in Diabetes, Nov 30-Dec 01, 2016, Berlin, Germany; Managing Outsourced Clinical Trials, January 25-26, 2017, Miami, USA. The European Personalized Medicine Association (EPEMED), The Institute of Clinical Research (ICR), The BioIndustry Association (BIA), Canadian Generic Pharmaceutical Association (CGPA), The British Generic Manufacturers Association.

Track-6: Quality Control

Quality control (QC) is a procedure or set of procedures intended to ensure that a manufactured product or performed service adheres to a defined set of quality criteria that meets the requirements of the client or customer. A major aspect of quality control is the establishment of well-defined controls. These controls help standardize both production and reactions to quality issues. The role of Quality Impact Assessment & effectiveness checks is an essential operation of the pharmaceutical industry. To Perform Quality Control process of Project Management several quality control tools and software’s are required. Quality control also plays a major role in analytical method development so it would be great to attend the quality control summit.

Related Conferences:

7^th Analytical & Bioanalytical Techniques Conference, Sept 28-30, 2016, Orlando, USA; Annual Pharmaceutical Analysis Conference, Sep 25-27, 2017, Vienna, Austria; 2^nd  Separation Techniques Conference, Oct 31 - Nov 2, 2016,  Valencia, Spain; Pharmaceutical Methods Development and Validation Conference, November 24-25, 2016, Dubai, UAE; 3^rd Conference on Mass spectrometry, October 10-11, 2016, Kuala Lumpur, Malaysia; 18th Conference on Pharmaceutical Regulatory Affairs, August 8 - 9, 2016,Venice, Italy; Global Pharmaceutical Regulatory Affairs Summit, October 18 – 20, 2016, Berlin, Germany; Convention on Quality Control Circles (ICQCC 2016), August 23-26, 2016, Bangkok, Thailand; 22nd Asia Pacific Quality Conference, November 20-23, 2016, Rotorua, New Zealand; 22nd Symposium on Quality Function Deployment, September 07-16, 2016, Boise, USA. Generic Pharmaceutical Association, National Association of Pharmaceutical Manufacturers, European Generic medicines Association, Generic Pharmaceutical Manufacturers Association, European Association of Euro-Pharmaceutical Companies (EAEPC).

Track-7: Quality Assurance

Quality assurance is defined as a procedure or set of procedures intended to ensure that a product or service under development meets specified requirements. A quality assurance system is said to increase customer confidence and a company's credibility, to improve work processes and efficiency, and to enable a company to better compete with others. Quality assurance conferences aims at the need for Effective Internal and External Quality Assurance Auditing and it is required, by all active pharmaceutical ingredient (API)/bulk pharmaceutical chemical, medical device and finished pharmaceutical cGMP regulations published worldwide. Quality assurance testing is done by using software called Quality Metrics.

Related Conferences:

7^th Analytical & Bioanalytical Techniques Conference, Sept 28-30, 2016, Orlando, USA; Annual Pharmaceutical Analysis Conference, Sep 25-27, 2017, Vienna, Austria; 2^nd Separation Techniques Conference, Oct 31 - Nov 2, 2016,  Valencia, Spain; Middle East Surgical and Medical Devices Expo, October 10-12, 2016, Dubai, UAE; Pharmaceutical Method Development and Validation Conference, November 24-25, 2016, Dubai, UAE; 18th Conference on Pharmaceutical Regulatory Affairs, August 8 - 9, 2016,Venice, Italy; Global Pharmaceutical Regulatory Affairs Summit, October 18 – 20, 2016, Berlin, Germany; Data Integrity Validation, September 17-18, 2016, San Diego, CA; IVT’s 2^nd Annual Data Integrity Validation Conference, August 17–18, 2016, Boston, USA; MES 2016, August 10-11, 2016, Philadelphia, USA. Japan Generic Pharmaceutical Manufacturers Association, Association of the British Pharmaceutical Industry, Pharmaceutical Association for the Development of the Republic of China (CPMDA), The Danish Association of the Pharmaceutical Industry, Belgian Pharmaceutical Industry Association.

Track-8: Validation

Validation means establishing documented evidence that provides a high degree of assurance that a specific process will consistently produce a product meeting its predetermined specifications and quality attributes. Validation is an integral part of quality assurance; it involves the systematic study of systems, facilities and processes aimed at determining whether they perform their intended functions adequately and consistently as specified. The Major Phases of validation include Pre validation, Process Validation and Validation maintenance Phase.

Related Conferences:

Pharma Marketing Conference, November 17-19, 2016, Alicante, Spain; Global Pharmaceutical Industry Summit, August 22-24, 2016, Vienna, Austria; 6^th Pharmaceutical Conference on Regulatory Affairs and IPR, Sept 29- Oct 01, 2016 Orlando, USA; Conference on Generic Drug Market and Contract Manufacturing, Oct 31- Nov 02, 2016, Valencia, Spain; 6^th Biologics and Biosimilars Conference, October 19-21, 2016, Houston, USA; IVT’s 22nd Annual Validation Week, October 18–20, 2016, San Diego, USA; IVT’s 2^nd Annual Data Integrity Validation Conference, August 17–18, 2016, Boston, USA; Analytical Procedures and Methods Validation EU, June 21-23, 2016, Dublin, Ireland; IVT’s ACE Conference, August 22-24, 2016, Philadelphia, USA; MES 2016, August 10-11, 2016, Philadelphia, USA. Generic Pharmaceutical Manufacturers Association, European Association of Euro-Pharmaceutical Companies (EAEPC), The European Federation of Pharmaceutical Industries and Associations (EFPIA), The European Generic Medicines Association (EGA), The Controlled Release Society (CRS).

Track-9: Contract & Sterile/Aseptic Manufacturing

Traditional role of Contract manufacturing, also known as outsource manufacturing, is to produce one or more components of a final product in which a company relies on the skills of specialist manufacturers. Six Sigma is a long-term, forward-thinking initiative designed to fundamentally change the way corporations do business. It is first and foremost "a business process that enables companies to increase profits dramatically by streamlining operations, improving quality, and eliminating defects or mistakes in everything a company does. Aseptic/sterile production and injectable manufacturing processes require a significant investment in terms of expertise, equipment, process, technology and quality control.

Related Conferences:

Pharma Marketing Conference, November 17-19, 2016, Alicante, Spain; Global Pharmaceutical Industry Summit, August 22-24, 2016, Vienna, Austria; 6^th 6^th Pharmaceutical Conference on Regulatory Affairs and IPR, Sept 29- Oct 01, 2016, Orlando, USA; Conference on Generic Drug Market and Contract Manufacturing, Oct 31- Nov 02, 2016, Valencia, Spain; 6^th Biologics and Biosimilars Conference, October 19-21, 2016, Houston, USA; Asia-Pacific Drug Formulation & Bioavailability Congress, June 6-8, 2016, Beijing, China; 6th Drug Formulation, Solubility & Bioavailability, March 20-22, 2017, Philadelphia, USA; 2nd Annual Oral Drug Formulation Innovations Summit, September 29-30, 2016, Philidelphia, USA; 2016 PDA/FDA Joint Regulatory Conference, Sep 12 - Sep 14, 2016 | Washington, USA; CMC Regulatory Compliance for Biopharmaceuticals, September 22-23, 2016, Rome, Italy. Canadian Society for Pharmaceutical Sciences (CSPS), Drug Information Association (DIA), Society for Pharmaceutical Engineering (ISPE), The European Generic Medicines Association (EGA), The Controlled Release Society (CRS).

Track-10: Storage, Distribution, Transportation

Cold chain storage is a temperature-controlled supply chain. An unbroken cold chain is an uninterrupted series of storage and distribution activities which maintain a given temperature range. It is used to help extend and ensure the shelf life of pharmaceutical drugs. Good distribution practice (GDP) deals with the guidelines for the proper distribution of medicinal products for human use. GDP is a quality warranty system, which includes requirements for purchase, receiving, storage and export of drugs intended for human consumption. Supply Chain integrity, enable qualified firms to expedite the importation of active pharmaceutical ingredients and finished drug products.

Related Conferences:

Pharma Marketing Conference, November 17-19, 2016, Alicante, Spain; Global Pharmaceutical Industry Summit, August 22-24, 2016, Vienna, Austria; 6^th 6^th Pharmaceutical Conference on Regulatory Affairs and IPR, September 12-14, 2016, San Antonio, USA; Conference on Generic Drug Market and Contract Manufacturing, Oct 31- Nov 02, 2016, Valencia, Spain; 6^th  Biologics and Biosimilars Conference, October 19-21, 2016, Houston, USA; Interest Group Meeting on Pharmaceutical Good Cold Chain, October 10, 2016, Amsterdam, The Netherlands: 6th Drug Formulation, Solubility & Bioavailability, March 20-22, 2017, Philadelphia, USA; 2nd Annual Oral Drug Formulation Innovations Summit, September 29-30, 2016, Philidelphia, USA; 2016 PDA/FDA Joint Regulatory Conference, Sep 12 - Sep 14, 2016 | Washington, USA; CMC Regulatory Compliance for Biopharmaceuticals, September 22-23, 2016, Rome, Italy. International Pharmaceutical Federation (FIP), Pharmaceutical Society of Australia, Chinese Pharmaceutical Association, American Association of Pharmaceutical Scientists (AAPS), Canadian Generic Pharmaceutical Association (CGPA).

Track-11: Formulation Development

Formulation development is to be done only after successful completion of pre-formulation studies. Optimization of existing formulations is required to create new products, Reduce costs, to capitalize on trends with greater profitability, novel formulations for improved delivery of existing dosage forms, to quickly recalculate formulations based on defined criteria, to create compliant products faster by using existing validated formulas. Product/Process optimization is the practice of making changes or adjustments to a process such as Conjoint Analysis, typically used in industrial process optimization.

Related Conferences:

Drug Formulation & Bioavailability Congress, September 05-07, 2016, Beijing, China; Biopharmaceutics Conference, September 14-16, 2016, San Antonio, USA; 10th Conference on Pharmaceutics & Novel Drug Delivery Systems, March 13-15, 2017, London, UK; 6^th Asia-Pacific Pharma Congress, July 11-13, 2016, Kualalumpur, Malaysia; 9th World Drug Delivery Summit, June 30-July 02, 2016, New Orleans, USA; Asia-Pacific Drug Formulation & Bioavailability Congress, June 6-8, 2016, Beijing, China; 6th Drug Formulation, Solubility & Bioavailability, March 20-22, 2017, Philadelphia, USA; 2nd Annual Oral Drug Formulation Innovations Summit, September 29-30, 2016, Philidelphia, USA; 2016 PDA/FDA Joint Regulatory Conference, Sep 12 - Sep 14, 2016 | Washington, USA; CMC Regulatory Compliance for Biopharmaceuticals, September 22-23, 2016, Rome, Italy. The European Personalized Medicine Association (EPEMED), The Institute of Clinical Research (ICR), The BioIndustry Association (BIA), Canadian Generic Pharmaceutical Association (CGPA), The British Generic Manufacturers Association.

Track-12: GMP in Food Industry

The Quality control in typical food processing has a significant role in assuming a high quality, safe and nutritious food supply for the public, for their good health and for the economic benefits derived from trade of safe and high quality food. Quality control conference also plays a major role in food industry. Hazard Analysis & Critical Control Points (HACCP) is a management system in which food safety is addressed through the analysis and control of biological, chemical, and physical hazards from raw material production, procurement and handling, to manufacturing, distribution and consumption of the finished product. Food, Drug, and Cosmetic Act is a set of laws giving authority to the US-FDA to oversee the food safety, safety of drugs, and cosmetics. Cleaning, disinfection and hygiene should be strictly maintained in food industry.

Related Conferences:

10^th Global Food Processing Summit, December 5-7, 2016, San Antonio, USA; Pharma Marketing Conference, November 10-11, 2016, Alicante, Spain; 2^nd Conference on Food Safety and Regulatory Measures, June 06-08, 2016, London, UK; Conference on Generic Drug Market and Contract Manufacturing, Oct 31- Nov 02, 2016, Valencia, Spain; 5^th Conference on Global Food Safety, December 05- 07, 2016, San Antonio, USA; 18th IUFOST – World Congress of Food Science and Technology, August 21-25, 2016, Dublin, Ireland; 12^th Conference on Food Studies - A Common Ground Conference, October 12-13, 2016 Berkeley, USA; 3^rd Conference on Food Sciences and Health (ICFSH 2016), November 26-28, 2016, Sydney, Australia; Conference on Nutrition and Food Engineering (ICNFE 2016), August 19-21, 2016, Budapest, Hungary; Conference on Biotechnology, Food Science, and Pharmaceutical Research, August 3-5, 2016, Kuala Lumpur, Malaysia. Generic Pharmaceutical Manufacturers Association, European Association of Euro-Pharmaceutical Companies (EAEPC), The European Federation of Pharmaceutical Industries and Associations (EFPIA), The European Generic Medicines Association (EGA), The Controlled Release Society (CRS).

Track-13: GMP in Microbiology and Biotechnology

Microbiological Assay is defined as the determination or estimation of concentration or potency of an antibiotic by means of measuring and comparing the area of zone of inhibition or turbidity produced by test substance with that of standard over a suitable microbe under standard conditions. FDA 510k Testing regulation is found in 21 CFR 807 includes information required in a 510(k). The 510(k) is not a form. Cleaning, disinfection and hygiene should be strictly maintained in Microbiology and Biotechnology.

Related Conferences:

Conference on Food Microbiology, August 08-10, 2016, Birmingham, UK; Pharma Marketing Conference, November 17-19, 2016, Alicante, Spain; 11th World Congress on Biotechnology and Biotech Industries, July 28-29, 2016, Berlin, Germany; Conference on Generic Drug Market and Contract Manufacturing, Oct 31- Nov 02, 2016, Valencia, Spain; Biotechnology World Convention, August 15-17, 2016, Sao Paulo, Brazil; 5^th Conference on Clinical Microbiology and Microbial Genomics, October 24-26, 2016, Rome, Italy; Conference on Biotechnology, Food Science, and Pharmaceutical Research, August 3-5, 2016, Kuala Lumpur, Malaysia; Conference of Chemical, Pharmaceutical & Medical Sciences (ICCPMS), December 24-25, 2016, New Delhi, India; Conference on Nanotechnology (ICNT 2016), September 10-12, 2016, Kuala Lumpur, Malaysia; 11th Annual PDA Global Conference on Pharmaceutical Microbiology, October 26-27, 2016, Arlington, USA. International Pharmaceutical Federation (FIP), Pharmaceutical Society of Australia, Chinese Pharmaceutical Association, American Association of Pharmaceutical Scientists (AAPS), Austrian Pharmaceutical Society (APS).

Track-14: Softwares in GMP and GCP

The use of GMP software systems in regulated industries is vital throughout all aspects of the manufacturing process. Quality management software provides a flexible and configurable platform for tracking and managing quality and regulatory compliance events to ensure that manufacturing activities are continually measured, monitored and improved upon.  In addition to managing all aspects of the audit process, GMP software solution manages the associated findings or observations, corrective and preventive actions (CAPAs), risk assessment, risk management and the analysis and approvals of changes. This software also manages deviations, process validation, complaint handling, manufacturing incidents, training records and more.

Related Conferences:

7^th Analytical & Bioanalytical Techniques Conference, Sept 28-30, 2016, Orlando, USA; 2^nd  Separation Techniques Conference, Oct 31 - Nov 2, 2016, Valencia, Spain; Conference on Generic Drug Market and Contract Manufacturing, Nov 07- 09, 2016 Barcelona, Spain; 6^th Pharmaceutical Conference on Regulatory Affairs and IPR, Sept 29- Oct 01, 2016, Orlando, USA; Pharmaceutical Method Development and Validation Conference November 24-25, 2016 Dubai, UAE; IVT’s Computer and Software Validation (CSV) EU, December 1-3, 2016, Amsterdam, The Netherlands; R&D Financial Tracking and Analysis Summit, November 16-17, 2016, Philadelphia, PA; Data Integrity Validation, September 17-18, 2016, San Diego, CA; IVT’s 2^nd Annual Data Integrity Validation Conference, August 17–18, 2016, Boston, USA; MES 2016, August 10-11, 2016, Philadelphia, USA. Japan Generic Pharmaceutical Manufacturers Association, Association of the British Pharmaceutical Industry, Pharmaceutical Association for the Development of the Republic of China (CPMDA), The Danish Association of the Pharmaceutical Industry, Belgian Pharmaceutical Industry Association.